Association between the serum concentrations of 12 cytokines and growth factors and metabolic syndrome in patients undergoing angiography

References

• Alam, S. E. 2004. “Cytokine Imbalance in Acute Coronary Syndrome.” Current Opinion in Pharmacology 4 (2): 166–170.
   PubMed Web of Science ®Google Scholar
• Alberti, K. G. M., P. Zimmet, and J. Shaw. 2005. “The Metabolic Syndrome—A New Worldwide Definition.” The Lancet 366 (9491): 1059–1062.
   PubMed Web of Science ®Google Scholar
• Barati, E., H. Ghazizadeh, F. Sadabadi, E. Kazemi, G. A. Ferns, A. Avan, and M. Ghayour-Mobarhan. 2019. “Association of the IL6 Gene Polymorphism with Component Features of Metabolic Syndrome in Obese Subjects.” Biochemical Genetics 57(5): 695–708.
   PubMed Web of Science ®Google Scholar
• Biswas, S., P. K. Ghoshal, S. C. Mandal, and N. Mandal. 2010. “Relation of Anti-to Pro-Inflammatory Cytokine Ratios with Acute Myocardial Infarction.” The Korean Journal of Internal Medicine 25 (1): 44.
   PubMedGoogle Scholar
• Cornier, M.-A., D. Dabelea, T. L. Hernandez, R. C. Lindstrom, A. J. Steig, N. R. Stob, R. E. Van Pelt, et al. 2008. “The Metabolic Syndrome.” Endocrine Reviews 29 (7): 777–822.
   PubMed Web of Science ®Google Scholar
• Daniele, G., R. Guardado Mendoza, D. Winnier, T. V. Fiorentino, Z. Pengou, J. Cornell, F. Andreozzi, et al. 2014. “The Inflammatory Status Score Including IL-6, TNF-α, Osteopontin, Fractalkine, MCP-1 and Adiponectin Underlies Whole-Body Insulin Resistance and Hyperglycemia in Type 2 Diabetes Mellitus.” Acta Diabetologica 51 (1): 123–131.
   PubMed Web of Science ®Google Scholar
• Deng, T., C. J. Lyon, S. Bergin, M. A. Caligiuri, and W. A. Hsueh. 2016. “Obesity, Inflammation, and Cancer.” Annual Review of Pathology: Mechanisms of Disease 11 (1): 421–449.
   PubMedGoogle Scholar
• Ebrahimi, M., A. R. Heidari-Bakavoli, S. Shoeibi, S. R. Mirhafez, M. Moohebati, H. Esmaily, H. Ghazavi, et al. 2016. “Association of Serum hs-CRP Levels with the Presence of Obesity, Diabetes Mellitus, and Other Cardiovascular Risk Factors.” Journal of Clinical Laboratory Analysis 30 (5): 672–676.
   PubMed Web of Science ®Google Scholar
• FitzGerald, S. P., J. V. Lamont, R. I. McConnell, and El. O. Benchikh. 2005. “Development of a High-Throughput Automated Analyzer Using Biochip Array Technology.” Clinical Chemistry 51 (7): 1165–1176.
   PubMed Web of Science ®Google Scholar
• Ghattas, A., H. R. Griffiths, A. Devitt, G. Y. H. Lip, and E. Shantsila. 2013. “Monocytes in Coronary Artery Disease and Atherosclerosis: Where Are We Now?” Journal of the American College of Cardiology 62 (17): 1541–1551.
   PubMed Web of Science ®Google Scholar
• Ghazizadeh, H., M. Fazilati, A. Pasdar, A. Avan, M. Tayefi, F. Ghasemi, M. Mehramiz, et al. 2017. “Association of a Vascular Endothelial Growth Factor Genetic Variant with Serum VEGF Level in Subjects with Metabolic Syndrome.” Gene 598: 27–31.
   PubMed Web of Science ®Google Scholar
• Gnacińska, M., S. Małgorzewicz, W. Lysiak-Szydłowska, and K. Sworczak. 2010. “The Serum Profile of Adipokines in Overweight Patients with Metabolic Syndrome.” Endokrynologia Polska 61 (1): 36–41.
   PubMed Web of Science ®Google Scholar
• Grundy, S. M. 2004. “Obesity, Metabolic Syndrome, and Cardiovascular Disease.” The Journal of Clinical Endocrinology & Metabolism 89 (6): 2595–2600.
   PubMed Web of Science ®Google Scholar
• Hansson, G. K., and A. Hermansson. 2011. “The Immune System in Atherosclerosis.” Nature Immunology 12 (3): 204–212.
   PubMed Web of Science ®Google Scholar
• Harford, K. A., C. M. Reynolds, F. C. McGillicuddy, and H. M. Roche. 2011. “Fats, Inflammation and Insulin Resistance: Insights to the Role of Macrophage and T-Cell Accumulation in Adipose Tissue.” Proceedings of the Nutrition Society 70 (4): 408–417.
   PubMed Web of Science ®Google Scholar
• Hippenstiel, S., B. Schmeck, J. Seybold, M. Krüll, C. v. Eichel-Streiber, and N. Suttorp. 2002. “Reduction of Tumor Necrosis Factor-Alpha (TNF-α) Related Nuclear Factor-kappaB (NF-κB) Translocation but Not Inhibitor kappa-B (Iκ-B)-Degradation by Rho Protein Inhibition in Human Endothelial Cells.” Biochemical Pharmacology 64 (5–6): 971–977.
   PubMed Web of Science ®Google Scholar
• Huang, P. L. 2009. “eNOS, Metabolic Syndrome and Cardiovascular Disease.” Trends in Endocrinology & Metabolism 20 (6): 295–302.
   PubMed Web of Science ®Google Scholar
• Kang, Y. E., J. M. Kim, K. H. Joung, J. H. Lee, B. R. You, M. J. Choi, M. J. Ryu, et al. 2016. “The Roles of Adipokines, Proinflammatory Cytokines, and Adipose Tissue Macrophages in Obesity-Associated Insulin Resistance in Modest Obesity and Early Metabolic Dysfunction.” PlOS One 11 (4): e0154003.
   PubMed Web of Science ®Google Scholar
• Kim, J.-Y., E.-Y. Choi, H.-S. Mun, P.-K. Min, Y.-W. Yoon, B. Lee, B.-K. Hong, et al. 2013. “Usefulness of Metabolic Syndrome Score in the Prediction of Angiographic Coronary Artery Disease Severity According to the Presence of Diabetes Mellitus: Relation with Inflammatory Markers and Adipokines.” Cardiovascular Diabetology 12 (1): 140.
   PubMedGoogle Scholar
• Kowalska, I., M. Straczkowski, A. Nikolajuk, A. Adamska, M. Karczewska-Kupczewska, E. Otziomek, I. Kinalska, et al. 2008. “Insulin Resistance, Serum Adiponectin, and Proinflammatory Markers in Young Subjects with the Metabolic Syndrome.” Metabolism - Metabolism 57 (11): 1539–1544.
   PubMed Web of Science ®Google Scholar
• Kressel, G., B. Trunz, A. Bub, O. Hülsmann, M. Wolters, R. Lichtinghagen, D. O. Stichtenoth, and A. Hahn. 2009. “Systemic and Vascular Markers of Inflammation in Relation to Metabolic Syndrome and Insulin Resistance in Adults with Elevated Atherosclerosis Risk.” Atherosclerosis 202 (1): 263–271.
   PubMed Web of Science ®Google Scholar
• Libby, P. 2006. “Inflammation and Cardiovascular Disease Mechanisms.” The American Journal of Clinical Nutrition 83 (2): 456S–460S.
   PubMed Web of Science ®Google Scholar
• Libby, P., and P. Theroux. 2005. “Pathophysiology of Coronary Artery Disease.” Circulation 111 (25): 3481–3488.
   PubMed Web of Science ®Google Scholar
• Libby, P., P. M. Ridker, and A. Maseri. 2002. “Inflammation and Atherosclerosis.” Circulation 105 (9): 1135–1143.
   PubMed Web of Science ®Google Scholar
• Mälarstig, A., P. Eriksson, A. Hamsten, B. Lindahl, L. Wallentin, and A. Siegbahn. 2008. “Raised Interleukin-10 is an Indicator of Poor Outcome and Enhanced Systemic Inflammation in Patients with Acute Coronary Syndrome.” Heart (British Cardiac Society) 94 (6): 724–729.
   PubMed Web of Science ®Google Scholar
• Makki, K., P. Froguel, and I. Wolowczuk. 2013. “Adipose Tissue in Obesity-Related Inflammation and Insulin Resistance: Cells, Cytokines, and Chemokines.” ISRN Inflammation 2013: 1–12.
   Google Scholar
• Mardan-Nik, M., A. Pasdar, K. Jamialahmadi, A. Biabangard-Zak, S. R. Mirhafez, M. Ghalandari, M. Tajfard, et al. 2014. “Association of Heat Shock protein70-2 (HSP70-2) Gene Polymorphism with Coronary Artery Disease in an Iranian Population.” Gene 550 (2): 180–184.
   PubMed Web of Science ®Google Scholar
• Martin, R. M., D. Gunnell, E. Whitley, A. Nicolaides, M. Griffin, N. Georgiou, G. Davey Smith, et al. 2008. “Associations of Insulin-like Growth Factor (IGF)-I, IGF-II, IGF Binding Protein (IGFBP)-2 and IGFBP-3 with Ultrasound Measures of Atherosclerosis and Plaque Stability in an Older Adult Population.” The Journal of Clinical Endocrinology & Metabolism 93 (4): 1331–1338.
   PubMed Web of Science ®Google Scholar
• Martins, T. B., J. L. Anderson, J. B. Muhlestein, B. D. Horne, J. F. Carlquist, W. L. Roberts, H. R. Hill, and J. F. Carlquist. 2006. “Risk Factor Analysis of Plasma Cytokines in Patients with Coronary Artery Disease by a Multiplexed Fluorescent Immunoassay.” American Journal of Clinical Pathology 125 (6): 906–913.
   PubMed Web of Science ®Google Scholar
• Matsuzawa, Y. 2006. “The Metabolic Syndrome and Adipocytokines.” FEBS Letters 580 (12): 2917–2921.
   PubMed Web of Science ®Google Scholar
• Mirhafez, S. R., A. Zarifian, M. Ebrahimi, R. F. A. Ali, A. Avan, M. Tajfard, M. Mohebati, et al. 2015. “Relationship between Serum Cytokine and Growth Factor Concentrations and Coronary Artery Disease.” Clinical Biochemistry 48 (9): 575–580.
   PubMed Web of Science ®Google Scholar
• Mirhafez, S. R., M. Tajfard, A. Avan, A. Pasdar, R. Nedaeinia, M. Aghasizade, H. Davari, et al. 2016. “Association between Serum Cytokine Concentrations and the Presence of Hypertriglyceridemia.” Clinical Biochemistry 49 (10–11): 750–755.
   PubMed Web of Science ®Google Scholar
• Molloy, R. M., R. I. Mc Connell, J. V. Lamont, and S. P. FitzGerald. 2005. “Automation of Biochip Array Technology for Quality Results.” Clinical Chemistry and Laboratory Medicine 43 (12): 1303–1313.
   PubMed Web of Science ®Google Scholar
• Moss, J. W., and D. P. Ramji. 2016. “Cytokines: Roles in Atherosclerosis Disease Progression and Potential Therapeutic Targets.” Future Medicinal Chemistry 8 (11): 1317–1330.
   PubMed Web of Science ®Google Scholar
• Mottillo, S., K. B. Filion, J. Genest, L. Joseph, L. Pilote, P. Poirier, S. Rinfret, et al. 2010. “The Metabolic Syndrome and Cardiovascular Risk: A Systematic Review and Meta-Analysis.” Journal of the American College of Cardiology 56 (14): 1113–1132.
   PubMed Web of Science ®Google Scholar
• Namazi, N., B. Larijani, and L. Azadbakht. 2018. “Dietary Inflammatory Index and Its Association with the Risk of Cardiovascular Diseases, Metabolic Syndrome, and Mortality: A Systematic Review and Meta-Analysis.” Hormone and Metabolic Research 50 (05): 345–358.
   PubMedGoogle Scholar
• Noels, H., and C. Weber. 2010. “Fractalkine as an Important Target of Aspirin in the Prevention of Atherogenesis.” Cardiovascular Drugs and Therapy 24 (1): 1–3. Springer.
   PubMed Web of Science ®Google Scholar
• Nowbar, A. N., M.Gitto, J. P. Howard, D. P. Francis, and R. Al-Lamee. 2019. “Mortality from Ischemic Heart Disease: Analysis of Data from the World Health Organization and Coronary Artery Disease Risk Factors from NCD Risk Factor Collaboration.” Circulation: Cardiovascular Quality and Outcomes 12 (6): e005375.
   PubMed Web of Science ®Google Scholar
• Parizadeh, S. A., K. Jamialahmadi, H. Rooki, H. Zaim-Kohan, S. R. Mirhafez, N. Hosseini, J. Mohiti-Ardakani, et al. 2015. “Association of Neuropeptide Y Gene rs16147 Polymorphism with Metabolic Syndrome in Patients with Documented Coronary Artery Disease.” Annals of Human Biology 42 (2): 178–183.
   PubMed Web of Science ®Google Scholar
• Rajappa, M., S. Sen, and A. Sharma. 2009. “Role of Pro-/anti-Inflammatory Cytokines and Their Correlation with Established Risk Factors in South Indians with Coronary Artery Disease.” Angiology 60 (4): 419–426.
   PubMed Web of Science ®Google Scholar
• Rein, P., C. H. Saely, S. Beer, A. Vonbank, and H. Drexel. 2010. “Roles of the Metabolic Syndrome, HDL Cholesterol, and Coronary Atherosclerosis in Subclinical Inflammation.” Diabetes Care 33 (8): 1853–1855.
   PubMed Web of Science ®Google Scholar
• Tajfard, M., L. A. Latiff, H. R. Rahimi, M. Moohebati, M. Hasanzadeh, A. S. Emrani, H. Esmaeily, et al. 2017. “Serum Concentrations of MCP-1 and IL-6 in Combination Predict the Presence of Coronary Artery Disease and Mortality in Subjects Undergoing Coronary Angiography.” Molecular and Cellular Biochemistry 435 (1–2): 37–45.
   PubMed Web of Science ®Google Scholar
• Tousoulis, D., C. Antoniades, N. Koumallos, and C. Stefanadis. 2006. “Pro-Inflammatory Cytokines in Acute Coronary Syndromes: From Bench to Bedside.” Cytokine & Growth Factor Reviews 17 (4): 225–233.
   PubMed Web of Science ®Google Scholar
• Wang, Z., and T. Nakayama. 2010. “Inflammation, a Link between Obesity and Cardiovascular Disease.” Mediators of Inflammation 2010: 1–17.
   Google Scholar
• Wassmann, S., M. Stumpf, K. Strehlow, A. Schmid, B. Schieffer, M. BöHm, and G. Nickenig. 2004. “Interleukin-6 Induces Oxidative Stress and Endothelial Dysfunction by Overexpression of the Angiotensin II Type 1 Receptor.” Circulation Research 94 (4): 534–541.
   PubMed Web of Science ®Google Scholar
• Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante. 2003. “Obesity is Associated with Macrophage Accumulation in Adipose Tissue.” Journal of Clinical Investigation 112 (12): 1796–1808.
   PubMed Web of Science ®Google Scholar
• Weiss, T. W., H. Arnesen, and I. Seljeflot. 2013. “Components of the Interleukin-6 Transsignalling System Are Associated with the Metabolic Syndrome, Endothelial Dysfunction and Arterial Stiffness.” Metabolism 62 (7): 1008–1013.
   PubMed Web of Science ®Google Scholar
• Wojcik, B. M., S. K. Wrobleski, A. E. Hawley, T. W. Wakefield, D. D. Myers, and J. A. Diaz. 2011. “Interleukin-6: A Potential Target for Post-Thrombotic Syndrome.” Annals of Vascular Surgery 25 (2): 229–239.
   PubMed Web of Science ®Google Scholar
• Yaseen, F., A. Jaleel, J. Aftab, A. Zuberi, and E. Alam. 2012. “Circulating Levels of Resistin, IL-6 and Lipid Profile in Elderly Patients with Ischemic Heart Disease with and without Diabetes.” Biomarkers in Medicine 6 (1): 97–102.
   PubMed Web of Science ®Google Scholar
• Yudkin, J. S., M. Kumari, S. E. Humphries, and V. Mohamed-Ali. 2000. “Inflammation, Obesity, Stress and Coronary Heart Disease: Is Interleukin-6 the Link?” Atherosclerosis 148 (2): 209–214.
   PubMed Web of Science ®Google Scholar
• Ziccardi, P., F. Nappo, G. Giugliano, K. Esposito, R. Marfella, M. Cioffi, F. D’Andrea, et al. 2002. “Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women after Weight Loss over One Year.” Circulation 105 (7): 804–809.
   PubMed Web of Science ®Google Scholar